NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/06/2024
Voltar para busca
Dado oficial do USPTO
BIO-COURIER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
21
Atualização mais recente
25/06/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
23/12/2021
Data de registro
25/06/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/06/2024
Última transação
25/06/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Supplemental Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
GUILDFORD, Surrey, GB
Examinador
SORIANO, JASMINE
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
SISAF Ltd
Representantes
Evi Christou BANNER & WITCOFF, LTD.
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Nanoparticle substances and nanoparticles for use in industryscience and research; Siliconsilicon for use in industryscience and research in the nature of biochemical catalysts; Siliconsilicon nanoparticle materials for use in industryscience and research; Siliconporous silicon nanoparticle materials for use in industryscience and research; lipid nanoparticles for use in industryscience and research; Siliconsilicon-lipid nanoparticles for use in industryscience and research; Siliconsilicon-stabilised hybrid lipid nanoparticles for use in industryscience and research; Siliconsilicon-stabilised lipid nanoparticles for use in industryscience and research; stabilised lipid nanoparticles for use in industryscience and research; materials being silicon for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; Siliconsilicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; Siliconporous silicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; Siliconsilicon lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; Siliconsilicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; Siliconsilicon-stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacturing of pharmaceuticals; materials being silicon for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; Siliconsilicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; Siliconporous silicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; Siliconsilicon-lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; Siliconsilicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; Siliconsilicon-stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of pharmaceuticals; materials for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; Siliconsilicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; Siliconporous silicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; Siliconsilicon-lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; Siliconsilicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; Siliconsilicon-stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in gene therapy; materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; Siliconsilicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; Siliconporous silicon nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; Siliconsilicon-lipid nanoparticle materials for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; Siliconsilicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; Siliconsilicon-stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemical and biological substances for use in the manufacture of vaccines; materials for stabilising of chemicalbiochemical and biological substances; nanoparticle materials for stabilising of chemicalbiochemical and biological substances; Siliconsilicon nanoparticle materials for stabilising of chemicalbiochemical and biological substances; Siliconporous silicon nanoparticle materials for stabilising of chemicalbiochemical and biological substances; lipid nanoparticle materials for stabilising of chemicalbiochemical and biological substances; Siliconsilicon-lipid nanoparticle materials for stabilising of chemicalbiochemical and biological substances; Siliconsilicon-stabilised hybrid lipid nanoparticles for stabilising of chemicalbiochemical and biological substances; Siliconsilicon-stabilised lipid nanoparticles for stabilising of chemicalbiochemical and biological substances; stabilised lipid nanoparticles for stabilising of chemicalbiochemical and biological substances; materials for stabilising nucleic acids; nanoparticle materials for stabilising nucleic acids; Siliconsilicon nanoparticle materials for stabilising nucleic acids; Siliconporous silicon nanoparticle materials for stabilising nucleic acids; lipid nanoparticle materials for stabilising nucleic acids; Siliconsilicon-lipid nanoparticle materials for stabilising nucleic acids; Siliconsilicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acids; Siliconsilicon-stabilised lipid nanoparticles for stabilising nucleic acids; stabilised lipid nanoparticles for stabilising nucleic acids; materials for stabilising nucleic acid-lipid complexes; nanoparticle materials for stabilising nucleic acid-lipid complexes; Siliconsilicon nanoparticle materials for stabilising nucleic acid-lipid complexes; Siliconporous silicon nanoparticle materials for stabilising of nucleic acid-lipid complexes; lipid nanoparticle materials for stabilising nucleic acid-lipid complexes; Siliconsilicon-lipid nanoparticle materials for stabilising nucleic acid-lipid complexes; Siliconsilicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acid-lipid complexes; Siliconsilicon-stabilised lipid nanoparticles for stabilising nucleic acid-lipid complexes; stabilised lipid nanoparticles for stabilising nucleic acid-lipid complexes; all of the foregoing other than for medical or veterinary purposes and excluding use in the agricultural industry
Classe 5
Nanoparticle substances and nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical purposes; silicon nanoparticle substances and silicon nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical purposes; porous silicon nanoparticle substances and porous silicon nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical purposes; lipid nanoparticle substances and lipid nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical purposes; silicon-lipid nanoparticle substances and silicon-lipid nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical purposes; silicon-stabilised hybrid lipid nanoparticles for medicalveterinary and nanoparticle substances and nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatments; silicon nanoparticle substances and silicon nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatments; porous silicon nanoparticle substances and porous silicon nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatments; lipid nanoparticle substances and lipid nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatments; silicon-lipid nanoparticle substances and silicon-lipid nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatments; nanoparticle substances and nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical treatment purposes; silicon nanoparticle substances and silicon nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical treatment purposes; porous silicon nanoparticle substances and porous silicon nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical treatment purposes; lipid nanoparticle substances and lipid nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical treatment purposes; silicon-lipid nanoparticle substances and lipid nanoparticle preparationsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines for medicalveterinary and pharmaceutical treatment purposes; silicon-stabilised hybrid lipid nanoparticles for medicalveterinary and pharmaceutical treatment purposes; silicon-stabilised lipid nanoparticles for medicalveterinary and pharmaceutical treatment purposes; stabilised lipid nanoparticles for medicalveterinary and pharmaceutical treatment purposes; materials for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; nanoparticle materials for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon nanoparticle materials for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; porous silicon nanoparticle materials for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; lipid nanoparticles for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-lipid nanoparticles for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; stabilised lipid nanoparticles for carrying and delivery of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; materials for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; nanoparticle materials for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon nanoparticle materials for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; porous silicon nanoparticle materials for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; lipid nanoparticles for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-lipid nanoparticles for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised hybrid lipid nanoparticles for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised lipid nanoparticles for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; stabilised lipid nanoparticles for stabilising of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; materials for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; nanoparticle materials for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon nanoparticle materials for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; porous silicon nanoparticle materials for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; lipid nanoparticles for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-lipid nanoparticles for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised lipid nanoparticles for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; stabilised lipid nanoparticles for stabilising nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; materials for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; nanoparticle materials for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon nanoparticle materials for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; porous silicon nanoparticle materials for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; lipid nanoparticles for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-lipid nanoparticles for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised lipid nanoparticles for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; stabilised lipid nanoparticles for stabilising nucleic acid-lipid complexesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; materials for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; nanoparticle materials for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon nanoparticle materials for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; porous silicon nanoparticle materials for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; lipid nanoparticle materials for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-lipid nanoparticle materials for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised hybrid lipid nanoparticles for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised lipid nanoparticles for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; stabilised lipid nanoparticles for controlled release and onset of chemicalbiochemicalbiological and pharmaceutical substancesdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; materials for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; nanoparticle materials for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon nanoparticle materials for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; porous silicon nanoparticle materials for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; lipid nanoparticle materials for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-lipid nanoparticle materials for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised hybrid lipid nanoparticles for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; silicon-stabilised lipid nanoparticles for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; stabilised lipid nanoparticles for controlled release and transfection of nucleic acidsdrug delivery agents in the form of compounds that facilitate delivery of a wide range of pharmaceuticals used in the formulation of medicinesvaccinesmedical treatmentsveterinary medicinesveterinary treatmentsveterinary vaccines; all of the foregoing excluding use in the agricultural industry
Publicações
Histórico de despachos e eventos da marca no USPTO.
21 publicações encontradas
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
25/06/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
22/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/04/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
15/01/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
15/01/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
16/10/2023
GNFR
FINAL REFUSAL E-MAILED
16/10/2023
CNFR
FINAL REFUSAL WRITTEN
16/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/09/2023
ALIE
ASSIGNED TO LIE
05/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/04/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/10/2022
GNRT
NON-FINAL ACTION E-MAILED
27/10/2022
CNRT
NON-FINAL ACTION WRITTEN
27/10/2022
DOCK
ASSIGNED TO EXAMINER
27/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/12/2021
NWAP
NEW APPLICATION ENTERED
27/12/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIO-COURIER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.